Ginkgo biloba for Tardive Dyskinesia and Plasma MnSOD Activity: Association with MnSOD Ala-9Val Variant: A Randomized, Double-blind Trial
Wang D, Tian Y, Chen J, Zhu R, Li J, Zhou H, Chen D, Wang L, Kosten T, Zhang X. Ginkgo biloba for Tardive Dyskinesia and Plasma MnSOD Activity: Association with MnSOD Ala-9Val Variant: A Randomized, Double-blind Trial. Current Neuropharmacology 2024, 22: 2443-2452. PMID: 38919004, PMCID: PMC11451319, DOI: 10.2174/1570159x22666240530095721.Peer-Reviewed Original ResearchAbnormal Involuntary Movement ScaleMnSOD Ala-9Val polymorphismTardive dyskinesiaTD patientsTD symptomsAla-9Val polymorphismPathophysiology of tardive dyskinesiaNon-TDHealthy controlsNon-TD patientsSeverity of TDMovement ScaleAla alleleDouble-blind clinical trialIncreased MnSOD activityMnSOD activityWeeks of treatmentVal/Val genotypeTreatment responseDyskinesiaGinkgo biloba extractEGb761 groupManganese superoxide dismutaseSymptomsClinical trials